Search

Jennifer E. Graser

Examiner (ID: 2460)

Most Active Art Unit
1645
Art Unit(s)
1802, 1645, 1641, 1621
Total Applications
1924
Issued Applications
1280
Pending Applications
238
Abandoned Applications
464

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17748191 [patent_doc_number] => 20220226394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => ALGORIPHAGUS SP, BOSEA SP, BREVUNDIMONAS SP, DESULFOVIBRIO SP, MICROBACTERIUM SP, SPHINGOMONAS SP, AND VARIOVORAX SP FOR USE IN DISEASE PREVENTION AND TREATMENT [patent_app_type] => utility [patent_app_number] => 17/576339 [patent_app_country] => US [patent_app_date] => 2022-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5732 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17576339 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/576339
ALGORIPHAGUS SP, BOSEA SP, BREVUNDIMONAS SP, DESULFOVIBRIO SP, MICROBACTERIUM SP, SPHINGOMONAS SP, AND VARIOVORAX SP FOR USE IN DISEASE PREVENTION AND TREATMENT Jan 13, 2022 Pending
Array ( [id] => 19032563 [patent_doc_number] => 20240082378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => Staphylococcus aureus Antigen-Based Nucleic Acid Vaccines [patent_app_type] => utility [patent_app_number] => 18/261568 [patent_app_country] => US [patent_app_date] => 2022-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58932 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261568 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/261568
Staphylococcus aureus Antigen-Based Nucleic Acid Vaccines Jan 13, 2022 Pending
Array ( [id] => 19032563 [patent_doc_number] => 20240082378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => Staphylococcus aureus Antigen-Based Nucleic Acid Vaccines [patent_app_type] => utility [patent_app_number] => 18/261568 [patent_app_country] => US [patent_app_date] => 2022-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58932 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261568 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/261568
Staphylococcus aureus Antigen-Based Nucleic Acid Vaccines Jan 13, 2022 Pending
Array ( [id] => 18986462 [patent_doc_number] => 20240058431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-22 [patent_title] => NOVEL COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/270947 [patent_app_country] => US [patent_app_date] => 2022-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14321 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270947 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/270947
NOVEL COMPOSITION Jan 4, 2022 Pending
Array ( [id] => 18953627 [patent_doc_number] => 20240041954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => USE OF LACTIC ACID BACTERIA TO INHIBIT METHANOGEN GROWTH OR REDUCE METHANE EMISSIONS [patent_app_type] => utility [patent_app_number] => 18/259014 [patent_app_country] => US [patent_app_date] => 2021-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20746 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259014 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/259014
USE OF LACTIC ACID BACTERIA TO INHIBIT METHANOGEN GROWTH OR REDUCE METHANE EMISSIONS Dec 21, 2021 Pending
Array ( [id] => 18953674 [patent_doc_number] => 20240042001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => IRRADIATED WHOLE-CELL IMMUNOGENS OF ACINETOBACTER BAUMANNII [patent_app_type] => utility [patent_app_number] => 18/258842 [patent_app_country] => US [patent_app_date] => 2021-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11739 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258842 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/258842
IRRADIATED WHOLE-CELL IMMUNOGENS OF ACINETOBACTER BAUMANNII Dec 20, 2021 Pending
Array ( [id] => 18953674 [patent_doc_number] => 20240042001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => IRRADIATED WHOLE-CELL IMMUNOGENS OF ACINETOBACTER BAUMANNII [patent_app_type] => utility [patent_app_number] => 18/258842 [patent_app_country] => US [patent_app_date] => 2021-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11739 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258842 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/258842
IRRADIATED WHOLE-CELL IMMUNOGENS OF ACINETOBACTER BAUMANNII Dec 20, 2021 Pending
Array ( [id] => 17671029 [patent_doc_number] => 20220184196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING AUTOIMMUNE DISEASES [patent_app_type] => utility [patent_app_number] => 17/556294 [patent_app_country] => US [patent_app_date] => 2021-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43844 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556294 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/556294
Methods and compositions for treating and diagnosing autoimmune diseases Dec 19, 2021 Issued
Array ( [id] => 17671029 [patent_doc_number] => 20220184196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING AUTOIMMUNE DISEASES [patent_app_type] => utility [patent_app_number] => 17/556294 [patent_app_country] => US [patent_app_date] => 2021-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43844 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556294 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/556294
Methods and compositions for treating and diagnosing autoimmune diseases Dec 19, 2021 Issued
Array ( [id] => 17704573 [patent_doc_number] => 20220204579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => METHODS OF PRODUCING AGGREGATE-FREE MONOMERIC DIPHTHERIA TOXIN FUSION PROTEINS AND THERAPEUTIC USES [patent_app_type] => utility [patent_app_number] => 17/549845 [patent_app_country] => US [patent_app_date] => 2021-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15358 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17549845 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/549845
Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses Dec 12, 2021 Issued
Array ( [id] => 17704573 [patent_doc_number] => 20220204579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => METHODS OF PRODUCING AGGREGATE-FREE MONOMERIC DIPHTHERIA TOXIN FUSION PROTEINS AND THERAPEUTIC USES [patent_app_type] => utility [patent_app_number] => 17/549845 [patent_app_country] => US [patent_app_date] => 2021-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15358 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17549845 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/549845
Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses Dec 12, 2021 Issued
Array ( [id] => 17640671 [patent_doc_number] => 20220168409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-02 [patent_title] => VACCINES [patent_app_type] => utility [patent_app_number] => 17/644019 [patent_app_country] => US [patent_app_date] => 2021-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17484 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17644019 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/644019
Vaccines Dec 12, 2021 Issued
Array ( [id] => 18893816 [patent_doc_number] => 20240009301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => IMMUNOGENIC COMPOSITIONS FOR PRODUCING NEUTRALISING ANTIBODIES AGAINST SARS-COV [patent_app_type] => utility [patent_app_number] => 18/265081 [patent_app_country] => US [patent_app_date] => 2021-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17442 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265081 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/265081
IMMUNOGENIC COMPOSITIONS FOR PRODUCING NEUTRALISING ANTIBODIES AGAINST SARS-COV Dec 2, 2021 Pending
Array ( [id] => 17748243 [patent_doc_number] => 20220226446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => NEUROTOXIN COMPOSITIONS FOR USE IN IMPROVING LUNG FUNCTION [patent_app_type] => utility [patent_app_number] => 17/457369 [patent_app_country] => US [patent_app_date] => 2021-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14403 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17457369 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/457369
NEUROTOXIN COMPOSITIONS FOR USE IN IMPROVING LUNG FUNCTION Dec 1, 2021 Abandoned
Array ( [id] => 17611856 [patent_doc_number] => 20220154135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-19 [patent_title] => Live Attenuated Non-Transmissible Vaccines [patent_app_type] => utility [patent_app_number] => 17/532784 [patent_app_country] => US [patent_app_date] => 2021-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23708 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532784 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/532784
Live Attenuated Non-Transmissible Vaccines Nov 21, 2021 Pending
Array ( [id] => 18634858 [patent_doc_number] => 11759429 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-19 [patent_title] => Vaccine delivery systems using yeast cell wall particles [patent_app_type] => utility [patent_app_number] => 17/532656 [patent_app_country] => US [patent_app_date] => 2021-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 11923 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532656 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/532656
Vaccine delivery systems using yeast cell wall particles Nov 21, 2021 Issued
Array ( [id] => 17457954 [patent_doc_number] => 20220071258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => Composition and Method for Germinative Compounds in Probiotic Food and Beverage Products for Human Consumption [patent_app_type] => utility [patent_app_number] => 17/530731 [patent_app_country] => US [patent_app_date] => 2021-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8637 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17530731 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/530731
Composition and method for germinative compounds in probiotic food and beverage products for human consumption Nov 18, 2021 Issued
Array ( [id] => 18931081 [patent_doc_number] => 11883475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-30 [patent_title] => Infectious [patent_app_type] => utility [patent_app_number] => 17/529812 [patent_app_country] => US [patent_app_date] => 2021-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 16 [patent_no_of_words] => 9834 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17529812 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/529812
Infectious Nov 17, 2021 Issued
Array ( [id] => 17482123 [patent_doc_number] => 20220089627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => STAPHYLOCOCCUS AUREUS TYPE 8 CAPSULAR SACCHARIDES [patent_app_type] => utility [patent_app_number] => 17/528426 [patent_app_country] => US [patent_app_date] => 2021-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19616 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17528426 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/528426
STAPHYLOCOCCUS AUREUS TYPE 8 CAPSULAR SACCHARIDES Nov 16, 2021 Abandoned
Array ( [id] => 18893017 [patent_doc_number] => 20240008502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => LACTIC ACID BACTERIAL STRAIN WITH IMPROVED TEXTURIZING PROPERTIES [patent_app_type] => utility [patent_app_number] => 18/253180 [patent_app_country] => US [patent_app_date] => 2021-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7836 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18253180 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/253180
LACTIC ACID BACTERIAL STRAIN WITH IMPROVED TEXTURIZING PROPERTIES Nov 15, 2021 Pending
Menu